Clobetasol propionate spray 0.05% for the treatment of moderate to severe plaque psoriasis.
نویسنده
چکیده
Clobetasol propionate is a super-high potent class 1 topical corticosteroid available in several formulations, including a spray formulation that is approved for use up to 4 weeks in patients aged 18 years and older with moderate to severe plaque psoriasis. The efficacy and safety of clobetasol propionate spray 0.05% has been extensively evaluated in clinical trials in more than 2200 patients with moderate to severe plaque psoriasis. This article reviews the efficacy, safety, and tolerability of clobetasol propionate spray 0.05%. Clobetasol propionate spray 0.05% is a topical product with a documented efficacy and safety profile with good acceptability in patients with moderate to severe plaque psoriasis.
منابع مشابه
Comparison of clinical efficacy of topical tazarotene 0.1% cream with topical clobetasol propionate 0.05% cream in chronic plaque psoriasis: a double-blind, randomized, right-left comparison study.
BACKGROUND No controlled data is available till date comparing topical tazarotene and clobetasol in Indian psoriatic patients. OBJECTIVE The aim was to compare the clinical efficacy of 12 weeks of once-daily tazarotene 0.1% cream with that of once-daily clobetasol propionate 0.05% cream in the treatment of patients with chronic plaque psoriasis. METHODS About 36 patients with bilaterally sy...
متن کاملTreatment of psoriatic nails with tazarotene cream 0.1% vs. clobetasol propionate 0.05% cream: a double-blind study.
Sir, Nail psoriasis affects 20–55% of psoriatic patients. It often represents a significant cause of distress because of the visible lesions and the chronic course of the disease. Treatment options include corticosteroids, vitamin D3 analogues, 5-fluorouracil, urea, anthralin, cyclosporine and radiotherapy (1). Tazarotene is an acetylenic retinoid with documented therapeutic results in skin pso...
متن کاملMedication formulation affects quality of life: a randomized single-blind study of clobetasol propionate foam 0.05% compared with a combined program of clobetasol cream 0.05% and solution 0.05% for the treatment of psoriasis
Study sample The sample size was not determined in the planning phase of the study, and power calculations were not performed retrospectively. Initially, 7 women and 25 men (mean age 49 years) were enrolled in the study, all being residents of the San Francisco Bay area. Three patients were excluded and a justification for their exclusion was provided. The number of patients allocated to the tw...
متن کاملSelective persistence of dermal CD8+ T cells in lesional plaque psoriasis after clobetasol-17 propionate treatment.
In psoriasis, T-cell infiltration and epidermal hyperproliferation are key phenomena which are closely related. Our aim was to investigate the dynamics among T-cell subsets in relation to epidermal proliferation and clinical severity in psoriasis during treatment with an ultra-potent corticosteroid. Seven psoriasis patients were treated twice daily for 14 days with clobetasol-17 propionate oint...
متن کاملNail psoriasis: a combined treatment using calcipotriol cream and clobetasol propionate cream.
Table I. Patients’ own opinion regarding eYcacy after 12 Sir, months Calcipotriol, a vitamin D derivative, has proven to be eVective in the treatment of nail psoriasis (1–4). The Hands (n= 48) Feet (n= 53) purpose of this open study was to evaluate the eYcacy n (%) n (%) and safety of the combined treatment of nail psoriasis Poor 3 (6.2) 6 (11.3 ) with calcipotriol cream and clobetasol propiona...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Cutis
دوره 89 2 شماره
صفحات -
تاریخ انتشار 2012